OTCMKTS:GNGBY - GETINGE AB/ADR Stock Price, News, & Analysis Sign in or create an account to add this stock to your watchlist. Get Started $9.90 +0.13 (+1.33 %) (As of 12/12/2018 11:44 AM ET)Previous Close$9.7660Today's Range$9.89 - $9.9352-Week Range$8.31 - $19.30Volume1,042 shsAverage Volume12,531 shsMarket Capitalization$2.41 billionP/E Ratio21.53Dividend Yield1.30%Beta1.65 ProfileDiscussionChartEarningsHeadlinesSocial Media Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email Getinge AB provides solutions for operating rooms, intensive-care units, sterilization departments, and life science companies and institutions. The company operates through Acute Care Therapies, Surgical Workflows, and Life Science segments. It offers anesthesia systems, acute care ventilation and hemodynamic monitoring, covered stents, aortic surgical and peripheral vascular grafts, thoracic drainage, surgery perfusion, extracorporeal life support, cardiac assist, endoscopic vessel harvesting systems, beating heart surgery products. The company also provides surgical tables and lamps, ceiling service units, wall modules, and hybrid operating rooms (OR); infection control products; integrated workflow solutions, including sterile supply management, patient flow optimization, and OR integration; and life science, such as sterilizers, cleaning and asepsis products, and isolators. It offers its products through a network of proprietary sales companies, as well as through agents and distributors in Europe, the Middle East, Africa, the Americas, Asia, and Pacific. The company has a strategic partnership with Verb Surgical Inc. to develop digital surgery solutions. Getinge AB was founded in 1904 and is headquartered in Gothenburg, Sweden. Receive GNGBY News and Ratings via Email Sign-up to receive the latest news and ratings for GNGBY and its competitors with MarketBeat's FREE daily newsletter. Industry, Sector and Symbol Stock Exchange OTCMKTS Industry Electromedical equipment Sub-IndustryN/A SectorMedical Current SymbolOTCMKTS:GNGBY Previous Symbol CUSIPN/A Webwww.getinge.com Phone46-1-033-500-00 Debt Debt-to-Equity Ratio0.55 Current Ratio2.60 Quick Ratio1.55 Price-To-Earnings Trailing P/E Ratio21.53 Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual Sales$5.27 billion Price / Sales0.48 Cash Flow$2.3131 per share Price / Cash Flow4.28 Book Value$9.14 per share Price / Book1.08 Profitability EPS (Most Recent Fiscal Year)N/A Net Income$161.40 million Net Margins3.49% Return on Equity4.75% Return on Assets2.22% Miscellaneous EmployeesN/A Outstanding Shares254,150,000Market Cap$2.41 billion OptionableNot Optionable GETINGE AB/ADR (OTCMKTS:GNGBY) Frequently Asked Questions What is GETINGE AB/ADR's stock symbol? GETINGE AB/ADR trades on the OTCMKTS under the ticker symbol "GNGBY." When is GETINGE AB/ADR's next earnings date? GETINGE AB/ADR is scheduled to release their next quarterly earnings announcement on Wednesday, December 12th 2018. View Earnings Estimates for GETINGE AB/ADR. Has GETINGE AB/ADR been receiving favorable news coverage? Media coverage about GNGBY stock has trended positive this week, according to InfoTrie Sentiment. The research firm identifies positive and negative press coverage by analyzing more than six thousand news and blog sources in real-time. The firm ranks coverage of companies on a scale of negative five to five, with scores nearest to five being the most favorable. GETINGE AB/ADR earned a daily sentiment score of 2.3 on InfoTrie's scale. They also gave media coverage about the company a news buzz of 0.0 out of 10, indicating that recent press coverage is extremely unlikely to have an impact on the company's share price in the near term. Who are some of GETINGE AB/ADR's key competitors? Some companies that are related to GETINGE AB/ADR include Masimo (MASI), LivaNova (LIVN), NxStage Medical (NXTM), CONMED (CNMD), AxoGen (AXGN), Natus Medical (BABY), Viewray (VRAY), Cutera (CUTR), BioLife Solutions (BLFS), Semler Scientific (SMLR), Rockwell Medical (RMTI), Electrocore (ECOR), Fonar (FONR), Zynex (ZYXI) and Second Sight Medical Products (EYES). Who are GETINGE AB/ADR's key executives? GETINGE AB/ADR's management team includes the folowing people: Mr. Mattias Perjos M.Sc., CEO, Pres & Director (Age 46)Mr. Lars Sandström M.Sc., Chief Financial Officer (Age 46)Lars Mattsson, Head of Investor RelationsMs. Lena Hagman B.Sc., Exec. VP of Quality & Regulatory Compliance (Age 53)Mr. Abraham Ronai, Gen. Counsel How do I buy shares of GETINGE AB/ADR? Shares of GNGBY can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab. What is GETINGE AB/ADR's stock price today? One share of GNGBY stock can currently be purchased for approximately $9.90. How big of a company is GETINGE AB/ADR? GETINGE AB/ADR has a market capitalization of $2.41 billion and generates $5.27 billion in revenue each year. What is GETINGE AB/ADR's official website? The official website for GETINGE AB/ADR is http://www.getinge.com. How can I contact GETINGE AB/ADR? GETINGE AB/ADR's mailing address is Lindholmspiren 7a Box 8861, Gothenburg V7, 402 72. The company can be reached via phone at 46-1-033-500-00 or via email at [email protected] MarketBeat Community Rating for GETINGE AB/ADR (OTCMKTS GNGBY)Community Ranking: 2.2 out of 5 ( )Outperform Votes: 35 (Vote Outperform)Underperform Votes: 46 (Vote Underperform)Total Votes: 81MarketBeat's community ratings are surveys of what our community members think about GETINGE AB/ADR and other stocks. Vote "Outperform" if you believe GNGBY will outperform the S&P 500 over the long term. Vote "Underperform" if you believe GNGBY will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 12/12/2018 by MarketBeat.com StaffFeatured Article: Should you buy a closed-end mutual fund?